#biotech

🏢Release 📈 Stocks

ProBio Inc. Clears NMPA Pre-Approval Inspection for Biologics Facility

October 21, 2026 (20 days ago)

ProBio Inc. secures a critical regulatory win as the NMPA completes its pre-approval inspection, signaling a positive outlook for the firm's biologics…

ProBio Inc.

🌍 ASIA Read More →

🏢Release 📈 Stocks

CSL Names Deborah Waterhouse as CEO Effective February 1, 2027

October 21, 2026 (20 days ago)

CSL Limited announces the appointment of Deborah Waterhouse as CEO starting February 2027, signaling a major leadership shift for the ASX-listed biotechnology…

CSL

🌍 OCEANIA Read More →

🏢Release 📈 Stocks

Lakewood-Amedex Shares Rise on Positive Nu-3 Preclinical Data

October 21, 2026 (20 days ago)

Lakewood-Amedex (LABT) advances its clinical pipeline after presenting data showing Nu-3's broad-spectrum efficacy and low resistance potential in treating diabetic foot ulcers.

LABT

🌍 AMERICAS Read More →

🏢Release 📈 Stocks

Genprex Shares Advance as New Study Links TUSC2 to Brain Health Mechanisms

October 21, 2026 (20 days ago)

Genprex gains attention as new preclinical data identifies TUSC2's critical role in brain aging and mitochondrial health, bolstering the long-term development outlook…

GNPX

🌍 AMERICAS Read More →

🏢Release 📈 Stocks

Patronus Biotech Secures Approval for Phase I Malaria Vaccine Clinical Trial

October 21, 2026 (20 days ago)

Patronus Biotech advances its malaria vaccine pipeline after receiving regulatory approval for a Phase I human trial in Australia targeting two primary…

Patronus Biotech

🌍 OCEANIA Read More →

🏢Release 📈 Stocks

CSL Appoints Deborah Waterhouse as CEO Effective 1 February 2027

October 21, 2026 (20 days ago)

CSL Limited announces the appointment of Deborah Waterhouse as CEO and Managing Director, with the transition set to take effect on 1…

CSL

🌍 OCEANIA Read More →

📊Earnings 📈 Stocks

Samsung Biologics Raises 2026 Revenue Guidance to 20% After Strong Q3 Results

October 21, 2026 (20 days ago)

Samsung Biologics lifts 2026 revenue growth outlook to 20% following a strong Q3 performance, supported by increased capacity at Plant 5 and…

207940.KS

🌍 ASIA Read More →

🏢Release 📈 Stocks

Hengrui Pharma Secures 64 ESMO 2026 Abstracts to Bolster Oncology Pipeline

October 21, 2026 (20 days ago)

Hengrui Pharma strengthens its oncology portfolio as 64 abstracts, including key proffered papers on HER2 and HER3 antibody-drug conjugates, are accepted for…

600276.SS

🌍 ASIA Read More →

🏢Release 📈 Stocks

Hengrui Pharma Shares 64 Research Findings at ESMO 2026 Oncology Conference

October 21, 2026 (20 days ago)

Hengrui Pharma secures 64 research presentations at ESMO 2026, showcasing significant progress in its oncology pipeline with a focus on HER2- and…

600276.SS

🌍 ASIA Read More →

🏢Release 📈 Stocks

Fortrea Expands Clinical Development Network via Worldwide Clinical Acquisition

October 20, 2026 (20 days ago)

Fortrea strengthens its early-stage clinical development footprint by integrating Worldwide Clinical Trials' specialized services, enhancing its bioanalytical platform and research capacity.

FTRE

🌍 AMERICAS Read More →

🏢Release 📈 Stocks

TNutra Launches NeuraLegend Brain Health System to Expand Product Portfolio

October 20, 2026 (20 days ago)

TNutra expands its wellness portfolio with the introduction of NeuraLegend, a comprehensive three-part daily supplement system engineered by chemist Kevin Palmer to…

TNutra

🌍 AMERICAS Read More →

🏢Release 📈 Stocks

Ionis Pharmaceuticals Gains Momentum as Hypertriglyceridemia Market Expands

October 20, 2026 (21 days ago)

Ionis Pharmaceuticals benefits from a growing cardiometabolic treatment market, supported by the approval of TRYNGOLZA and rising demand for therapies addressing severe…

IONS

🌍 GLOBAL Read More →